Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02141022 · ClinicalTrials.gov registry record · NA
Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya
A NA study, sponsored by Stony Brook University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02141022 is a NA study that has completed, run by Stony Brook University. The registered enrollment target is 20 participants.
The verdict
NCT02141022, a NA study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is investigating the efficacy of computer-based cognitive exercises as a means of cognitive remediation in patients with Multiple Sclerosis (MS) who are beginning the disease modifying pharmacotherapy Gileyna.
Interventions
- OTHER plasticity-based computerized cognitive remediation program
- DRUG Gileyna
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2013-08 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02141022
The ClinicalTrials.gov registry entry for NCT02141022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stony Brook University, which has 127 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which plasticity-based computerized cognitive remediation program is the first listed.
NCT02141022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02141022 about?
NCT02141022 is a clinical study titled "Computerized Exercise Training for Cognitive Remediation in Adults With Multiple Sclerosis Treated With Gilenya". This study is investigating the efficacy of computer-based cognitive exercises as a means of cognitive remediation in patients with Multiple Sclerosis (MS) who are beginning the disease modifying pharmacotherapy Gileyna.
What is the current status of trial NCT02141022?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2013-08. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02141022?
The interventions under investigation include: plasticity-based computerized cognitive remediation program (OTHER), Gileyna (DRUG).
Who is sponsoring clinical trial NCT02141022?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.